Chronic pain is the most common cause of long-term disability in the United States, affecting 50 million Americans. Ameritox, the leader in pain medication monitoring, has announced the launch of Rx Guardian CD, its next-generation pain medication monitoring solution and part of the patented Rx Guardian process. This new science will help physicians interpret patients' urine drug test (UDT) results so they can identify potential misuse, abuse or diversion of opioid pain medications. A propriety algorithm and reference database of more than 1,000 chronic pain patients assessed for adherence to their prescription regimens, Rx Guardian CD will assist clinicians as they evaluate if patients are taking medications as prescribed.
All Comments